4//SEC Filing
Edwards Larry Todd 4
Accession 0001787306-24-000136
CIK 0001787306other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:55 PM ET
Size
5.6 KB
Accession
0001787306-24-000136
Insider Transaction Report
Form 4
Edwards Larry Todd
See Remarks
Transactions
- Sale
Common Stock
2024-10-02$10.01/sh−3,725$37,295→ 136,635 total
Footnotes (2)
- [F1]The sale was made pursuant to the Issuer's mandatory sell-to-cover requirements implemented to satisfy the tax withholding obligations associated with the vesting of the Reporting Person's Restricted Stock Units ("RSUs").
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $9.51 to $10.31, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001994805
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:55 PM ET
- Size
- 5.6 KB